Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Dent Res ; 101(12): 1450-1456, 2022 11.
Artigo em Inglês | MEDLINE | ID: mdl-35727681

RESUMO

The airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) via respiratory fluids and droplets suggests that mouthwashes containing substances with virucidal activity can help reduce viral spread. We conducted a multicenter, double-blind, placebo-controlled, randomized trial to assess the virucidal activity of cetylpyridinium chloride (CPC) mouthwashes. Outpatients who tested positive for SARS-CoV-2 infection with or without symptoms were randomized to perform washes and gargles for 1 min with 15 mL of either colored distilled water or 0.07% CPC (Vitis CPC Protect) mouthwash. The study outcomes were the SARS-CoV-2 log10 viral RNA load and the nucleocapsid protein levels, both in saliva at 1 and 3 h after the intervention. In total, 118 patients were enrolled and randomized (mean [SD], age 46 [14] y). Thirteen of 118 participants (11%) did not complete follow-up or had insufficient sample volume for testing and were excluded from the analysis. The assessment of the viral load showed no significant differences between groups at any of the investigated points. However, the levels of SARS-CoV-2 nucleocapsid protein of lysed viruses were significantly higher in the CPC group compared with the control group at 1 h (adjusted difference 269.3 pg/mL; 95% confidence interval [CI], 97.1-441.5) and at 3 h postintervention (561.1 pg/mL; 95% CI, 380.0-742.2). In nonhospitalized patients with asymptomatic or mild symptomatic SARS-CoV-2 infection, a 0.07% CPC mouthwash, compared to placebo, was associated with a significant increase of nucleocapsid protein levels in saliva, indicating enhanced disruption of viral particles.


Assuntos
COVID-19 , Cetilpiridínio , Antissépticos Bucais , SARS-CoV-2 , Eliminação de Partículas Virais , Humanos , Pessoa de Meia-Idade , Cetilpiridínio/uso terapêutico , Cloretos , Método Duplo-Cego , Antissépticos Bucais/uso terapêutico , Proteínas do Nucleocapsídeo , RNA Viral , Eliminação de Partículas Virais/efeitos dos fármacos
2.
Pathol Biol (Paris) ; 50(2): 118-26, 2002 Mar.
Artigo em Francês | MEDLINE | ID: mdl-11933832

RESUMO

Respiratory injuries by smoke inhalation are one of the most frequent reasons for acute respiratory failure in burn victims. They are most often of chemical origin and are responsible of a 20 to 70% increase of the mortality compared to the mortality of patients with similar burn injuries, but without inhalation lesions. They are often associated to a certain degree to other factors of acute respiratory failure: superior air way obstruction by oedema in face and neck burns, thoracic expansion hindrance due to thoracic burns, lung trauma lesions by blast injury. The generalized inflammatory reaction due to the extent of burns and an initial inadequate resuscitation are worsening factors. The inflammatory process may be responsible of lung injuries similar to those induced by smoke inhalation, even when there is no inhalation. The treatment remains symptomatic and based on the oxygen therapy, mechanical ventilation, prevention of infections and maintain of homeostasis by hydroelectrolytic adequate resuscitation. The nitric oxyde associated to the almitrin allows in a certain number of cases to minimize intra pulmonary shunting and to normalize the VA/O ratio. The development of treatments allowing to modulate inflammatory mediators may lead to news therapies in the future.


Assuntos
Queimaduras/complicações , Insuficiência Respiratória/etiologia , Lesão por Inalação de Fumaça/complicações , Doença Aguda , Queimaduras/terapia , Humanos , Inflamação/complicações , Inflamação/terapia , Lesão Pulmonar , Respiração Artificial , Insuficiência Respiratória/diagnóstico , Insuficiência Respiratória/fisiopatologia , Insuficiência Respiratória/terapia , Lesão por Inalação de Fumaça/diagnóstico , Lesão por Inalação de Fumaça/fisiopatologia , Lesão por Inalação de Fumaça/terapia
3.
Ann Chir Plast Esthet ; 46(3): 167-72, 2001 Jun.
Artigo em Francês | MEDLINE | ID: mdl-11447622

RESUMO

Mortality predictive factors of burned patients are analyzed in a population of 1929 patients by the statistical method of logistic regression. Among the variables studied (total burn skin area, deep burn area, superficial burn area, age, sex, burn location, preexisting disorders), two only, deep burn area and age, have been retained as predictive factors which, when associated, allow to classify 94.47% of the patients in either survival or death group. The prognosis weight of the deep burn area (SBP) is superior to that of the total burn skin area, yet retained in most previous studies. The superficial burn area, the inhalation injuries and the preexisting disorders are not factors determining prognosis. The F equation = e(-6.0061 + (0.0829*SBP) + (0.0443*%AGE)) resulting of the logistic regression, allows a direct evaluation of the death probability. A simple linear relation can be proposed as score of severity: IG = (2 x %SBP) + age. Below 80, mortality is close to zero, above mortality increases linearly up to 210, reaching 100%. This relation must be handled cautiously when comparing the severity score of two groups of patients, just as any other severity score that uses a linear relation with the burnt area associated or not to age.


Assuntos
Queimaduras/classificação , Queimaduras/mortalidade , Escala de Gravidade do Ferimento , Adolescente , Adulto , Distribuição por Idade , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Superfície Corporal , Queimaduras/diagnóstico , Queimaduras/etiologia , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Modelos Lineares , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Prognóstico , Fatores de Risco , Análise de Sobrevida
4.
Rev Esp Cardiol ; 49 Suppl 2: 22-31, 1996.
Artigo em Espanhol | MEDLINE | ID: mdl-8755693

RESUMO

Both atrial flutter and fibrillation are common arrhythmias in the clinical setting. Although we have been aware of them for decades, little has been known until recently about their triggering or maintenance mechanisms. The diagnosis of these arrhythmias lies largely in the electrocardiogram, which shows characteristic features of atrial electrical activity, leading to a correct diagnosis. Usually, some maneuvers such as adenosine infusion, carotidus sinus massage, etc., are required, in order to unmask the atrial activity, that are often obscured by the QRS complex or T wave. Several therapeutic options can be attempted for the acute termination of both atrial flutter and fibrillation episodes. The choice of one or another depends on some extent, on the clinical status of the patient during the arrhythmia, the presence of structural heart disease and the preceding arrhythmic history. Antiarrhythmic drugs are quite efficacious in the acute conversion of atrial fibrillation, but such an effect is not expected in atrial flutter. Drugs that depress AV nodal conduction can be used in both instances, as a therapeutic end-point or as a previous measure to the arrhythmia conversion. Direct current cardioversion is a good and efficacious option for both arrhythmias, however sedation is mandatory which, may be a contraindication in some patients. Rapid atrial pacing is an elegant and reliable method for the acute termination of atrial flutter of the common type, although a transvenous catheter insertion is needed.


Assuntos
Fibrilação Atrial/diagnóstico , Fibrilação Atrial/terapia , Flutter Atrial/diagnóstico , Flutter Atrial/terapia , Eletrocardiografia , Fibrilação Atrial/complicações , Fibrilação Atrial/fisiopatologia , Flutter Atrial/classificação , Flutter Atrial/fisiopatologia , Função Atrial , Humanos , Função Ventricular , Síndrome de Wolff-Parkinson-White/complicações , Síndrome de Wolff-Parkinson-White/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...